[HTML][HTML] Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
A new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
is the aetiological agent responsible for the 2019–2020 viral pneumonia outbreak of …
is the aetiological agent responsible for the 2019–2020 viral pneumonia outbreak of …
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has become a global crisis. Replication of SARS-…
syndrome coronavirus 2 (SARS-CoV-2), has become a global crisis. Replication of SARS-…
Structure of the CCR5 chemokine receptor–HIV entry inhibitor maraviroc complex
…, L Ma, G Fenalti, J Li, W Zhang, X Xie, H Yang, H Jiang… - Science, 2013 - science.org
The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry. Here we report the
2.7 angstrom–resolution crystal structure of human CCR5 bound to the marketed HIV drug …
2.7 angstrom–resolution crystal structure of human CCR5 bound to the marketed HIV drug …
[PDF][PDF] Structural insights into the human D1 and D2 dopamine receptor signaling complexes
The D1- and D2-dopamine receptors (D1R and D2R), which signal through G s and G i ,
respectively, represent the principal stimulatory and inhibitory dopamine receptors in the central …
respectively, represent the principal stimulatory and inhibitory dopamine receptors in the central …
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the etiological agent
responsible for the global COVID-19 (coronavirus disease 2019) outbreak. The main protease of …
responsible for the global COVID-19 (coronavirus disease 2019) outbreak. The main protease of …
Predicting protein–protein interactions based only on sequences information
…, W Zhu, K Yu, K Chen, Y Li, H Jiang - Proceedings of the …, 2007 - National Acad Sciences
Protein–protein interactions (PPIs) are central to most biological processes. Although efforts
have been devoted to the development of methodology for predicting PPIs and protein …
have been devoted to the development of methodology for predicting PPIs and protein …
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
…, J Allegood, GM Strub, EY Kim, M Maceyka, H Jiang… - Nature, 2010 - nature.com
Tumour-necrosis factor (TNF) receptor-associated factor 2 (TRAF2) is a key component in
NF-κB signalling triggered by TNF-α 1 , 2 . Genetic evidence indicates that TRAF2 is …
NF-κB signalling triggered by TNF-α 1 , 2 . Genetic evidence indicates that TRAF2 is …
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
G-protein-coupled receptors (GPCRs) signal primarily through G proteins or arrestins. Arrestin
binding to GPCRs blocks G protein interaction and redirects signalling to numerous G-…
binding to GPCRs blocks G protein interaction and redirects signalling to numerous G-…
PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach
…, J Gong, S Zheng, Z Li, H Li, H Jiang - Nucleic acids …, 2010 - academic.oup.com
In silico drug target identification, which includes many distinct algorithms for finding disease
genes and proteins, is the first step in the drug discovery pipeline. When the 3D structures …
genes and proteins, is the first step in the drug discovery pipeline. When the 3D structures …
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
…, Q Li, J Li, S Gong, H Zhou, J Gan, H Jiang… - Nucleic acids …, 2015 - academic.oup.com
Two human demethylases, the fat mass and obesity-associated (FTO) enzyme and ALKBH5,
oxidatively demethylate abundant N 6 -methyladenosine (m 6 A) residues in mRNA. …
oxidatively demethylate abundant N 6 -methyladenosine (m 6 A) residues in mRNA. …